| Dr Lindsay Marie Zeeb, MD | |
|
1500 E Medical Center Dr, B2 Floor Cancer & Geriatrics Center Rm B2205, Ann Arbor, MI 48109-5904 | |
| (734) 936-6274 | |
| Not Available |
| Full Name | Dr Lindsay Marie Zeeb |
|---|---|
| Gender | Female |
| Speciality | Diagnostic Radiology |
| Experience | 18 Years |
| Location | 1500 E Medical Center Dr, Ann Arbor, Michigan |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1215094149 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Midmichigan Medical Center-midland | Midland, MI | Hospital |
| Midmichigan Medical Center-clare | Clare, MI | Hospital |
| Midmichigan Medical Center-gladwin | Gladwin, MI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mymichigan Medical Center Midland | 2264323633 | 338 |
News Archive
Researchers at the University of Helsinki and the Folkh-lsan Research Center, Finland, have identified the genetic cause of early-onset progressive cerebellar degeneration the Finnish Hound dog breed. The study, led by Professor Hannes Lohi, revealed a new disease mechanism in cerebellar degeneration. A mutation was identified in the SEL1L gene, which has no previous link to inherited cerebellar ataxias.
The holidays are meant to be a time of celebration and quality time with family and friends. However, when trying to manage our families and navigate all of the festivities, this season is often a catalyst for a lot of stress and anxiety.
Oncolytics Biotech Inc. ("Oncolytics") (TSX:ONC, NASDAQ: ONCY) today announced that it has submitted an application for Orphan Drug Designation to the U.S. Food and Drug Administration ("FDA") for REOLYSIN® for the treatment of high grade gliomas (HGG) in pediatric patients.
Expected Republican wins in Congress and in statehouses throughout the country Tuesday would likely slow down implementation of the law and make the debate even more contentious but not outright stop the law.
In this morning's headlines - Medicaid enrollment spikes and the interplay between the federal government and McDonald's gets more attention.
› Verified 2 days ago
| Entity Name | Mymichigan Medical Center Midland |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1205889490 PECOS PAC ID: 2264323633 Enrollment ID: O20040324000137 |
News Archive
Researchers at the University of Helsinki and the Folkh-lsan Research Center, Finland, have identified the genetic cause of early-onset progressive cerebellar degeneration the Finnish Hound dog breed. The study, led by Professor Hannes Lohi, revealed a new disease mechanism in cerebellar degeneration. A mutation was identified in the SEL1L gene, which has no previous link to inherited cerebellar ataxias.
The holidays are meant to be a time of celebration and quality time with family and friends. However, when trying to manage our families and navigate all of the festivities, this season is often a catalyst for a lot of stress and anxiety.
Oncolytics Biotech Inc. ("Oncolytics") (TSX:ONC, NASDAQ: ONCY) today announced that it has submitted an application for Orphan Drug Designation to the U.S. Food and Drug Administration ("FDA") for REOLYSIN® for the treatment of high grade gliomas (HGG) in pediatric patients.
Expected Republican wins in Congress and in statehouses throughout the country Tuesday would likely slow down implementation of the law and make the debate even more contentious but not outright stop the law.
In this morning's headlines - Medicaid enrollment spikes and the interplay between the federal government and McDonald's gets more attention.
› Verified 2 days ago
| Entity Name | Midland Radiology Associates Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1861419954 PECOS PAC ID: 5294798963 Enrollment ID: O20041104000742 |
News Archive
Researchers at the University of Helsinki and the Folkh-lsan Research Center, Finland, have identified the genetic cause of early-onset progressive cerebellar degeneration the Finnish Hound dog breed. The study, led by Professor Hannes Lohi, revealed a new disease mechanism in cerebellar degeneration. A mutation was identified in the SEL1L gene, which has no previous link to inherited cerebellar ataxias.
The holidays are meant to be a time of celebration and quality time with family and friends. However, when trying to manage our families and navigate all of the festivities, this season is often a catalyst for a lot of stress and anxiety.
Oncolytics Biotech Inc. ("Oncolytics") (TSX:ONC, NASDAQ: ONCY) today announced that it has submitted an application for Orphan Drug Designation to the U.S. Food and Drug Administration ("FDA") for REOLYSIN® for the treatment of high grade gliomas (HGG) in pediatric patients.
Expected Republican wins in Congress and in statehouses throughout the country Tuesday would likely slow down implementation of the law and make the debate even more contentious but not outright stop the law.
In this morning's headlines - Medicaid enrollment spikes and the interplay between the federal government and McDonald's gets more attention.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Lindsay Marie Zeeb, MD 3621 S State St, 700 Kms Place, Ann Arbor, MI 48108 Ph: (734) 936-2047 | Dr Lindsay Marie Zeeb, MD 1500 E Medical Center Dr, B2 Floor Cancer & Geriatrics Center Rm B2205, Ann Arbor, MI 48109-5904 Ph: (734) 936-6274 |
News Archive
Researchers at the University of Helsinki and the Folkh-lsan Research Center, Finland, have identified the genetic cause of early-onset progressive cerebellar degeneration the Finnish Hound dog breed. The study, led by Professor Hannes Lohi, revealed a new disease mechanism in cerebellar degeneration. A mutation was identified in the SEL1L gene, which has no previous link to inherited cerebellar ataxias.
The holidays are meant to be a time of celebration and quality time with family and friends. However, when trying to manage our families and navigate all of the festivities, this season is often a catalyst for a lot of stress and anxiety.
Oncolytics Biotech Inc. ("Oncolytics") (TSX:ONC, NASDAQ: ONCY) today announced that it has submitted an application for Orphan Drug Designation to the U.S. Food and Drug Administration ("FDA") for REOLYSIN® for the treatment of high grade gliomas (HGG) in pediatric patients.
Expected Republican wins in Congress and in statehouses throughout the country Tuesday would likely slow down implementation of the law and make the debate even more contentious but not outright stop the law.
In this morning's headlines - Medicaid enrollment spikes and the interplay between the federal government and McDonald's gets more attention.
› Verified 2 days ago
Chiemezie Chianotu Amadi, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 1500 E Medical Center Dr, Ann Arbor, MI 48109 Phone: 734-936-4000 | |
Patrick Charles Albus, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 1500 E Medical Center Dr, Ann Arbor, MI 48109 Phone: 734-936-4000 | |
Dr. Michael James Todd, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 1500 E Medical Center Dr, Ann Arbor, MI 48109 Phone: 734-936-4000 | |
Perry G Pernicano, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 1500 East Medical Center Dr, B1 Floor University Hospital Recp C, Ann Arbor, MI 48109 Phone: 734-936-4566 | |
Ellen G Hoeffner, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 1500 East Medical Center Dr, B1 Floor University Hospital Recp C, Ann Arbor, MI 48109 Phone: 734-936-4566 | |
Dr. Christopher Robert Nall, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 1500 E Medical Center Dr, Ann Arbor, MI 48109 Phone: 734-936-4000 | |
Dr. Stephen Michael Ascherl, M.D. Radiology Medicare: Not Enrolled in Medicare Practice Location: 2375 Newport Rd, Ann Arbor, MI 48103 Phone: 734-327-0649 Fax: 734-327-0649 |